Literature DB >> 16388854

Cytokine mapping of sera from women with preeclampsia and normal pregnancies.

Yvonne Jonsson1, Marie Rubèr, Leif Matthiesen, Göran Berg, Katri Nieminen, Surendra Sharma, Jan Ernerudh, Christina Ekerfelt.   

Abstract

INTRODUCTION: Preeclampsia is a pregnancy-specific syndrome. The immune system in preeclampsia is changed with an increased innate activity and there is a hypothesis of a shift towards Th1-type immunity. The aim of this study was to determine a spectrum of soluble immunological factors denoting different aspects of immune activation in third trimester sera from women with preeclampsia (N=15) and compare with levels in sera from normal pregnant women (N=15).
MATERIAL AND METHODS: IL-1beta, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12 p40, IL-13, IL-15, IL-17, IFN-alpha, IFN-gamma, TNF-alpha, GM-CSF, MIP-lalpha, MIP-1beta, MCP-1, eotaxin and RANTES were measured in serum using multiplex bead arrays. The levels of soluble CD14 and soluble IL-4 receptor were measured by enzyme-linked immunoassay (ELISA).
RESULTS: Preeclamptic women had significantly increased levels of circulating IL-6 (p=0.002), IL-8 (p=0.003) and soluble IL-4R (p=0.037), compared to women with normal pregnancies.
CONCLUSION: This study supports the hypothesis of increased inflammatory responses in preeclampsia, illustrated by the increased levels of IL-6 and IL-8. The finding of increased levels of soluble IL-4 receptor is an intriguing finding with several interpretations, which may partly support the hypothesis of a Th1 shift in preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16388854     DOI: 10.1016/j.jri.2005.10.007

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  65 in total

1.  Blockade of CD40 ligand for intercellular communication reduces hypertension, placental oxidative stress, and AT1-AA in response to adoptive transfer of CD4+ T lymphocytes from RUPP rats.

Authors:  Denise C Cornelius; Javier Castillo; Justin Porter; Lorena M Amaral; Nathan Campbell; Adrienne Paige; Alexia J Thomas; Ashlyn Harmon; Mark W Cunningham; Kedra Wallace; Florian Herse; Gerd Wallukat; Ralf Dechend; Babbette LaMarca
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-08-26       Impact factor: 3.619

2.  Repeated measures of inflammation and oxidative stress biomarkers in preeclamptic and normotensive pregnancies.

Authors:  Kelly K Ferguson; John D Meeker; Thomas F McElrath; Bhramar Mukherjee; David E Cantonwine
Journal:  Am J Obstet Gynecol       Date:  2016-12-30       Impact factor: 8.661

Review 3.  Toll-like receptors in pregnancy disorders and placental dysfunction.

Authors:  Joan K Riley; D Michael Nelson
Journal:  Clin Rev Allergy Immunol       Date:  2010-12       Impact factor: 8.667

4.  Seizures in Women with Preeclampsia: Mechanisms and Management.

Authors:  Marilyn J Cipolla; Richard P Kraig
Journal:  Fetal Matern Med Rev       Date:  2011-05

5.  Maternal plasma fetuin-A concentration is lower in patients who subsequently developed preterm preeclampsia than in uncomplicated pregnancy: a longitudinal study.

Authors:  Piya Chaemsaithong; Roberto Romero; Adi L Tarca; Steven J Korzeniewski; Alyse G Schwartz; Jezid Miranda; Ahmed I Ahmed; Zhong Dong; Sonia S Hassan; Lami Yeo; Tinnakorn Tinnakorn
Journal:  J Matern Fetal Neonatal Med       Date:  2014-09-29

6.  Role of IL-6 -174(G/C) promoter polymorphism in the etiology of early-onset preeclampsia.

Authors:  Sabnavis Sowmya; Aruna Ramaiah; Pratibha Nallari; Akka Jyothy; Ananthapur Venkateshwari
Journal:  Inflamm Res       Date:  2015-04-28       Impact factor: 4.575

7.  Mid-pregnancy circulating immune biomarkers in women with preeclampsia and normotensive controls.

Authors:  Brandie D Taylor; Gong Tang; Roberta B Ness; Jørn Olsen; David M Hougaard; Kristin Skogstrand; James M Roberts; Catherine L Haggerty
Journal:  Pregnancy Hypertens       Date:  2015-11-10       Impact factor: 2.899

Review 8.  Novel approaches for mechanistic understanding and predicting preeclampsia.

Authors:  Satyan Kalkunte; Zhongbin Lai; Wendy E Norris; Linda A Pietras; Neetu Tewari; Roland Boij; Stefan Neubeck; Udo R Markert; Surendra Sharma
Journal:  J Reprod Immunol       Date:  2009-10-17       Impact factor: 4.054

9.  Inflammatory markers in the second trimester prior to clinical onset of preeclampsia, intrauterine growth restriction, and spontaneous preterm birth.

Authors:  Sofie Haedersdal; Jannie D Salvig; Martine Aabye; Christian W Thorball; Morten Ruhwald; Steen Ladelund; Jesper Eugen-Olsen; Niels J Secher
Journal:  Inflammation       Date:  2013-08       Impact factor: 4.092

10.  Elevated maternal IL-16 levels, enhanced IL-16 expressions in endothelium and leukocytes, and increased IL-16 production by placental trophoblasts in women with preeclampsia.

Authors:  Yang Gu; David F Lewis; Kelli Deere; Lynn J Groome; Yuping Wang
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.